The Medical Futurist

JUNE 21, 2025

Treating less serious ailments gets faster, more targeted and more efficient, while the means for curing more serious and life-altering illnesses improve. However, things are moving fast, and success doesn’t come easy for the pioneers of any medical field. The Stanford Artificial Retina Project shows great promises.

Diabetes 105

Diabetes Patient-Centered IT Patients 105

FDA Law Blog

AUGUST 4, 2022

Pfizer manufactures tafamidis, a breakthrough treatment for a rare, progressive heart condition known as transthyretin amyloid cardiomyopathy. Most of these cases have settled out of court (see, for example, Actelion Pharmaceuticals , 2018; Astellas Pharma and Amgen , 2019; Gilead Sciences , 2020). Background.

Manufacturing 98

Manufacturing Medical Government IT 98

FDA Law Blog

OCTOBER 25, 2021

The Medical Device Amendments of 1976 created the initial premarket application (PMA) review and 510(k) substantial equivalence review processes. The regulatory uncertainty has ill?befitted befitted a very important pathway to market for novel medical devices. The new rule will be codified in 21 C.F.R. Part 860. 515(d)(2)(C).

Manufacturing 52

Manufacturing Government Specialization IT 52

GeriPal

MARCH 24, 2022

Then listen to these prior podcasts with Sean Morrison and Rebecca Sudore about this issue, and we recently discussed differences between Advance Care Planning and Serious Illness Communication with Juliet Jacobsen and Rachelle Bernacki. . 2018 Systematic Review of Systematic Reviews on ACP. Where does POLST fit in with this debate?

Illness 72

Illness IT Healthcare Patient-Centered 72